Charles Zhu Maintained (TNGX) at Strong Buy with Decreased Target to $14 on, May 24th, 2024
Charles Zhu of Guggenheim, Maintained "Tango Therapeutics, Inc." (TNGX) at Strong Buy with Decreased Target from $16 to $14 on, May 24th, 2024.
Charles has made no other calls on TNGX in the last 4 months.
There are 4 other peers that have a rating on TNGX. Out of the 4 peers that are also analyzing TNGX, 0 agree with Charles's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Charles
- Robert Driscoll of "Wedbush" Maintained at Buy with Decreased Target to $11 on, Thursday, May 23rd, 2024
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $17 on, Thursday, May 9th, 2024
- Eric Schmidt of "Cantor Fitzgerald" Initiated at Buy on, Thursday, April 4th, 2024
- Joseph Catanzaro of "Piper Sandler" Initiated at Buy and Held Target at $18 on, Monday, February 12th, 2024
Contributing Sources